Urogenital

What the laboratory says this test is for

See individual tests

What the laboratory says this test is for

The assay is intended to aid in the diagnosis of Bacterial vaginosis (BV), and Chlamydia trachomatis/Neisseria gonorrhoeae using clinician-collected and patient-collected vaginal swab specimens from individuals with a clinical presentation consistent with vaginitis and/or vaginosis.The BV test is an in vitro nucleic acid amplification test that utilizes real time transcription-mediated amplification (TMA) for detection and quantitation of ribosomal RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L. gasseri, L.crispatus, and L. jensenii), Gardnerella vaginalis, and Atopobium vaginae. The assay reports a qualitative result for BV and does not report results for individual organisms.For Chlamydia trachomatis and Neisseria gonorrhoeae, a target capture assay is utilized for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis and/or Neisseria gonorrhoeae.

What the laboratory says this test is for

Diagnosis of the three most common sexually transmitted infections.

What the laboratory says this test is for

To screen for the infection with Neisseria gonorrhoeae and Chlamydia trachomatis in vaginal, endocervical and urethral swabs or urine from men and women.

What the laboratory says this test is for

Urethritis is an inflammation of the urethra and is often due to sexually transmitted infections. It may be caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and/or Mycoplasma genitalium. The symptoms are a burning sensation while urinating, itching or burning near the opening of the penis, presence of blood in the semen or urine and discharge from the penis. A panel will help the clinician identify the cause of these symptoms.

What the laboratory says this test is for

Diagnosis of the four most common sexually transmitted infections.

What the laboratory says this test is for

To diagnose three sexually transmitted infections associated with vaginitis.

What the laboratory says this test is for

Urethritis is an inflammation of the urethra and is often due to sexually transmitted infections. It may be caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and/or Mycoplasma genitalium and Ureaplasma spp. A panel will help the clinician's ability to precisely identify the cause of these symptoms.

What the laboratory says this test is for

Diagnosis of the three most common sexually transmitted infections.

What the laboratory says this test is for

Cervicitis is an inflammation of the cervix and can be related to sexually transmitted infections. It may be caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium. Most women are asymptomatic. For those that present with symptoms, the symptoms are vaginal discharge, abnormal vaginal bleeding and pain during intercourse. A panel will help the clinician identify if the woman has an STI as the cause of Cervicitis.

What the laboratory says this test is for

Pelvic inflammatory disease (PID) is an infection of the female reproductive organs and often due to sexually transmitted infections. It may be caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and/or Mycoplasma genitalium. Most women are asymptomatic. For those that present with symptoms, the symptoms may include pain in the lower abdomen and pelvis, heavy vaginal discharge with an unpleasant odor, abnormal vaginal bleeding, and pain during intercourse. A panel will help the clinician identify the cause of these symptoms.

What the laboratory says this test is for

The assay is intended to aid in the diagnosis of vaginitis using clinician-collected and patient-collected vaginal swab specimens from individuals with a clinical presentation consistent with vaginitis. Testing for bacterial vaginosis (BV), vulvovaginal candidiasis and trichomoniasis, as well as Chlamydia trachomatis and Neisseria gonorrhoeae is included.The BV test is an in vitro nucleic acid amplification test that utilizes real time transcription-mediated amplification (TMA) for detection and quantitation of ribosomal RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L. gasseri, L.crispatus, and L. jensenii), Gardnerella vaginalis, and Atopobium vaginae. The assay reports a qualitative result for BV and does not report results for individual organisms.For vulvovaginal candidiasis and trichomoniasis, a real time transcription-mediated amplification (TMA) assay is used to detect and qualitatively report results for Candida species group (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis, C. glabrata), and Trichomonas vaginalis.For Chlamydia trachomatis and Neisseria gonorrhoeae, A target capture assay for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis and/or Neisseria gonorrhoeae is utilized.

What the laboratory says this test is for

If someone is at an increased risk for STIs, they should be tested for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium. A panel will help the clinician identify and treat the appropriate pathogen if present.

What the laboratory says this test is for

C. trachomatis infections are the leading cause of sexually transmitted diseases in the United States. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of Chlamydial infections are severe if left untreated. Approximately half of Chlamydial infections are asymptomatic.⁠⁠⁠⁠⁠⁠⁠Neisseria gonorrhoeae (gonococci) is the causative agent of gonorrhea. In men, this disease generally results in anterior urethritis accompanied by purulent exudate. In women, the disease is most often found in the cervix, but the vagina and uterus may also be infected.